Praxis Precision Medicines Earnings
NASDAQ: PRAXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Wed, Nov 4, 2026
Fiscal period
Sep/2026
EPS estimate
$-3.66
Praxis Precision Medicines earnings summary
Praxis Precision Medicines is scheduled to report Sep/2026 earnings on Nov 4, 2026, with analysts expecting EPS of $-3.66. In its most recent report on Aug 6, 2026 (Q2 2026), PRAX posted EPS of $-2.87. Across the last 16 reports, PRAX shares moved an average of 6.0% (in either direction) in the first trading session after results, rising 7 times and falling 9 times.
Summary generated from market data by MetaCap's automated system. Methodology
PRAX earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 6, 2026 | — | $-2.87 | — | +1.7% |
| May 7, 2026 | — | $-3.20 | — | +3.8% |
| Feb 19, 2026 | — | $-3.52 | — | +0.4% |
| Nov 5, 2025 | — | $-3.36 | — | +10.8% |
| Aug 4, 2025 | — | $-3.31 | — | +2.5% |
| May 2, 2025 | — | $-3.29 | — | -4.7% |
| Feb 28, 2025 | — | $-2.88 | — | -0.3% |
| Nov 6, 2024 | — | $-2.75 | — | -7.9% |
| Aug 13, 2024 | — | $-1.74 | — | -4.7% |
| May 13, 2024 | — | $-2.84 | — | -2.9% |
| Mar 5, 2024 | — | $1.99 | — | -1.5% |
| Nov 7, 2023 | — | $-2.72 | — | +5.1% |
| Aug 9, 2023 | — | $-7.38 | — | +30.9% |
| May 11, 2023 | — | $-10.58 | — | -1.0% |
| Feb 7, 2023 | — | $-65.86 | — | -12.2% |
| Nov 9, 2022 | — | $-0.96 | — | -5.2% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.